They reported that WAT is the primary source of GDF15 at the onset of obesity and T2D (due to macrophage accumulation), while the liver becomes more involved during progression to MASH, with GDF15 expression rising in hepatocytes as the disease advances (L'Homme et al. 2024). This evidence concerns the gene GDF15 and type 2 diabetes mellitus.